SENTAN Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

SENTAN Pharma General Information

Description

Operator of a biotechnology company intended to conduct research and development of nanoparticle formulations for cardiovascular agents. The company's services include contributing to the creation of innovative pharmaceuticals and medical devices, as well as health food using nanotechnology, enabling academic researchers to get outputs to the industry.

Contact Information

Formerly Known As
Advanced Medical Development
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9th Floor, 2-1 Shimokawabata-machi
  • Hakataza/West Bank Redevelopment Building, Hakata-ku
  • Fukuoka, 812-0027
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 9th Floor, 2-1 Shimokawabata-machi
  • Hakataza/West Bank Redevelopment Building, Hakata-ku
  • Fukuoka, 812-0027
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SENTAN Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 04-Dec-2025 Completed Generating Revenue
3. Secondary Transaction - Private 01-Feb-2024 Completed Generating Revenue
2. Seed Round 10-Dec-2020 $1.73M $1.81M Completed Generating Revenue
1. Corporate 01-Feb-2007 $83K $83K Completed Startup
To view SENTAN Pharma’s complete valuation and funding history, request access »

SENTAN Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A preferred
To view SENTAN Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SENTAN Pharma Patents

SENTAN Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026048769-A1 Excrement odor suppression composition, excrement odor suppression feed, and excrement odor suppression method Pending 28-Aug-2024
WO-2025254014-A1 Preparation and kit preparation Pending 03-Jun-2024
WO-2025243901-A1 Injection preparation Pending 21-May-2024
JP-2023122702-A Injection and use of particle for producing injection Pending 24-Feb-2022
EP-4470531-A1 Pharmaceutical composition for treating retinitis pigmentosa Pending 28-Jan-2022 A61K9/5153
To view SENTAN Pharma’s complete patent history, request access »

SENTAN Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SENTAN Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nippon Soda Holding Company Minority
QB Capital Venture Capital Minority
Kyushu University University Minority
To view SENTAN Pharma’s complete investors history, request access »

SENTAN Pharma FAQs

  • When was SENTAN Pharma founded?

    SENTAN Pharma was founded in 2007.

  • Where is SENTAN Pharma headquartered?

    SENTAN Pharma is headquartered in Fukuoka, Japan.

  • What is the size of SENTAN Pharma?

    SENTAN Pharma has 20 total employees.

  • What industry is SENTAN Pharma in?

    SENTAN Pharma’s primary industry is Drug Discovery.

  • Is SENTAN Pharma a private or public company?

    SENTAN Pharma is a Private company.

  • What is SENTAN Pharma’s current revenue?

    The current revenue for SENTAN Pharma is .

  • How much funding has SENTAN Pharma raised over time?

    SENTAN Pharma has raised $1.81M.

  • Who are SENTAN Pharma’s investors?

    Nippon Soda, QB Capital, and Kyushu University have invested in SENTAN Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process